146 related articles for article (PubMed ID: 34135598)
1. Durable Clinical Response to Immune and Targeted Therapies in an Elderly Man with Synchronous Gastric (HER2+) and Bladder Cancers: Case Report and Literature Review.
Tian X; Zhu Q; Zhang Z
Onco Targets Ther; 2021; 14():3701-3708. PubMed ID: 34135598
[TBL] [Abstract][Full Text] [Related]
2. HER2-positive gastric cancer with paraaortic nodal metastasis successfully resected after chemotherapy with trastuzumab: a case report.
Ikari N; Nakajima G; Taniguchi K; Sasagawa T; Narumiya K; Yamada T; Kudo K; Kitamura Y; Hayashi K; Nishikawa T; Yamamoto M
Anticancer Res; 2014 Feb; 34(2):867-72. PubMed ID: 24511024
[TBL] [Abstract][Full Text] [Related]
3. Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report.
Huang LT; Ma JT; Zhang SL; Li XH; Sun L; Jing W; Zhao JZ; Wang YR; Han CB
Front Oncol; 2019; 9():1453. PubMed ID: 31956604
[No Abstract] [Full Text] [Related]
4. Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
Hackshaw MD; Bui CL; Ladner A; Tu N; Islam Z; Ritchey ME; Salas M
Cancer Treat Res Commun; 2020; 24():100189. PubMed ID: 32673845
[TBL] [Abstract][Full Text] [Related]
5. Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report.
Sakaguchi M; Shimoike N; Akagawa S; Kanaya S
J Med Case Rep; 2019 Feb; 13(1):42. PubMed ID: 30791934
[TBL] [Abstract][Full Text] [Related]
6. Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature.
Goodman OB; Milowsky MI; Kaplan J; Hussain M; Nanus DM
J Med Case Rep; 2009 Sep; 3():9110. PubMed ID: 19918289
[TBL] [Abstract][Full Text] [Related]
7. Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
Gong J; Liu T; Fan Q; Bai L; Bi F; Qin S; Wang J; Xu N; Cheng Y; Bai Y; Liu W; Wang L; Shen L
BMC Cancer; 2016 Feb; 16():68. PubMed ID: 26857702
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Hayashi K; Nagasaki E; Nakada K; Tamura M; Arakawa Y; Uwagawa T; Yano S
J Infect Chemother; 2018 Apr; 24(4):298-301. PubMed ID: 29174919
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the HER2 targeted therapy of gastric cancer.
Matsuoka T; Yashiro M
World J Clin Cases; 2015 Jan; 3(1):42-51. PubMed ID: 25610849
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
[TBL] [Abstract][Full Text] [Related]
12. A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
Yatsuda Y; Hirose S; Ito Y; Onoda T; Sugiyama Y; Nagafuchi M; Suzuki H; Niisato Y; Tange Y; Ikeda T; Yamada T; Yamamoto Y; Ohyama Osawa M; Sakamoto N; Moriwaki T; Mizokami Y
Intern Med; 2021 Apr; 60(7):1011-1017. PubMed ID: 33162479
[TBL] [Abstract][Full Text] [Related]
13. Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
Al-Batran SE; Moorahrend E; Maintz C; Goetze TO; Hempel D; Thuss-Patience P; Gaillard VE; Hegewisch-Becker S
Oncologist; 2020 Aug; 25(8):e1181-e1187. PubMed ID: 32311799
[TBL] [Abstract][Full Text] [Related]
14. [Nivolumab Therapy for Synchronous Double Primary Lung and Gastric Cancers].
Hachisuka Y; Fujioka S; Uomoto M; Johira H
Gan To Kagaku Ryoho; 2020 Dec; 47(12):1711-1714. PubMed ID: 33342989
[TBL] [Abstract][Full Text] [Related]
15. Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-1 Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report.
Yu S; Cai L; Lin F; Wu X; Zhang C; Liu X; Li W
Onco Targets Ther; 2019; 12():7691-7698. PubMed ID: 31571920
[TBL] [Abstract][Full Text] [Related]
16. Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06).
Kimura Y; Fujii M; Masuishi T; Nishikawa K; Kunisaki C; Matsusaka S; Segawa Y; Nakamura M; Sasaki K; Nagao N; Hatachi Y; Yuasa Y; Asami S; Takeuchi M; Furukawa H; Nakajima T;
Gastric Cancer; 2018 May; 21(3):421-427. PubMed ID: 28936560
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of stage IV gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab].
Nakayama Y; Kawasaki H; Wajima N; Kimura A; Nakai M; Yonaiyama S; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2188-90. PubMed ID: 24394055
[TBL] [Abstract][Full Text] [Related]
18. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
[TBL] [Abstract][Full Text] [Related]
19. Multiple liver metastases with synchronous gastric and transverse colon cancer diagnosed by gastric perforation successfully treated by SOX plus bevacizumab and completely resected by surgery: a case report.
Matsumoto R; Mori S; Kita Y; Toda H; Sasaki K; Arigami T; Matsushita D; Kurahara H; Maemura K; Natsugoe S
Surg Case Rep; 2020 Mar; 6(1):51. PubMed ID: 32180030
[TBL] [Abstract][Full Text] [Related]
20. The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond.
Kelly CM; Janjigian YY
J Gastrointest Oncol; 2016 Oct; 7(5):750-762. PubMed ID: 27747089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
